A Deep Learning-Generated Mixed Tumor–Stroma Ratio for Prognostic Stratification and Multi-omics Profiling in Bladder Cancer
<b>Background:</b> Quantifying tumor-stroma architecture on routine hematoxylin and eosin slides may refine risk stratification in bladder cancer (BCa). We developed a convolutional neural network to segment whole-slide images, compute the mixed tumor-stroma ratio (MTSR), evaluate its prognostic value across multicenter cohorts, explore underlying molecular programs through multi-omics analysis, and construct a preoperative multiparametric MRI (mpMRI) radiomics model to estimate MTSR noninvasively. <b>Methods:</b> The ResNet50 convolutional network was customized using The Cancer Genome Atlas BCa slides labeled into 9 histological classes and background, followed by internal validation and multicenter external testing. Whole-slide-image-level segmentation yielded quantitative tissue ratios. The prognostic value was evaluated using Cox regression, Kaplan-Meier analysis, and meta-analysis, with a nomogram constructed by incorporating independent predictors. Prognostic significance was assessed by Cox regression, Kaplan-Meier analysis, and meta-analysis, and a nomogram was developed by integrating independent predictors. Bulk RNA sequencing underwent gene set variation analysis/gene set enrichment analysis, immune deconvolution, and ESTIMATE analyses, while single-cell RNA sequencing of high- vs. low-MTSR tumors profiled cellular heterogeneity, pseudotime trajectories, and regulon activity using SCENIC. An mpMRI-based random forest radiomics model was trained to predict high vs. low MTSR. <b>Results:</b> The convolutional neural network achieved >90% classification accuracy with Cohen's kappa >0.95 in all cohorts. A nomogram combining MTSR and N stage outperformed clinicopathological predictors. Molecular analyses revealed that high-MTSR tumors displayed increased macrophage infiltration and enrichment of pathways related to extracellular matrix remodeling, cell adhesion, and transforming growth factor-β/WNT signaling. Single-cell analysis identified an integrin subunit beta 8 (ITGB8)-high urothelial subtype (cluster 8) with terminal differentiation, enhanced WNT activity, and sender-dominant communication networks. The mpMRI radiomics model achieved accuracies of 0.701 and 0.710 for predicting MTSR status in the training and validation sets, respectively. <b>Conclusions:</b> The deep learning-generated MTSR showed consistent reproducibility and prognostic independence across cohorts, mechanistically connected with an ITGB8-enriched stromal-oncogenic pathway. Its estimation via mpMRI radiomics enables integrative, noninvasive risk stratification for precision management of BCa.
Authors
- Xiaofu Qiu (ORCID: https://orcid.org/0000-0002-9246-6531)
- Harsh K. Patel (ORCID: https://orcid.org/0000-0002-9180-2150)
- Miaoxiao Wang (ORCID: https://orcid.org/0000-0002-4636-0058)
- Yadong Guo (ORCID: https://orcid.org/0000-0002-6684-7015)
- Feihan F. Dai (ORCID: https://orcid.org/0000-0001-6819-791X)
- Hongchang Lai (ORCID: https://orcid.org/0000-0002-6922-2918)
- Jinbo Xie (ORCID: https://orcid.org/0000-0003-3274-8059)
- Zhe‐Sheng Chen (ORCID: https://orcid.org/0000-0002-8289-097X)
- Sabrina Kailu Zhong (ORCID: https://orcid.org/0009-0002-3225-5254)
- Yifeng He (ORCID: https://orcid.org/0000-0003-2345-0736)
- Zongtai Zheng (ORCID: https://orcid.org/0000-0001-7962-5166)
- Yanyan He
- Changxin Zhan
- Bi‐ling Zhong
Institutions
- Wannan Medical College (CN)
- St. John's University (US)
- Jinan University (CN)
- Shantou University (CN)
- Second Affiliated Hospital of Guangzhou Medical University (CN)
- Longgang Central Hospital (CN)
- ShenZhen People’s Hospital (CN)
- Yue Bei People's Hospital (CN)
- Shanghai Tenth People's Hospital (CN)
- Punan Hospital (CN)
- Guangdong Provincial People's Hospital (CN)
- First Affiliated Hospital of Wannan Medical College (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Research
- Published
- 2025-12-04
- DOI
- https://doi.org/10.34133/research.1053
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00